康乃德生物醫藥 CNTB 深 滬
已收盤 02-06 16:00:00 美东时间
2.43
+0.130
+5.65%
華盛通- 最 高2.57
- 今 開2.34
- 成交量 7.09万股
- 最 低 2.23
- 昨 收 2.30
- 總市值 1.36亿
- 52周最高 3.28
- 市盈率 靜 --
- 換手率 0.13%
- 52周最低 0.51
- 委 比 70.63%
- 總股本 5590.35万
- 歷史最高 29.274
- 量 比 1.01
- 振 幅 14.78%
- 歷史最低 0.51
- 每 手 1
- 風險率 0.69%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Connect Biopharma Expects To Report Topline Data From Phase 1b Intravenous Administration Study In Q1 And Seabreeze STAT Studies In Acute Asthma And COPD Midyear
– Announced new data demonstrating a unique mechanism of action supporting the best-in-class potential of rademikibart –– Recruitment ongoing for Phase 1b study of intravenously-administered rademikibart designed to
01-12 21:12
Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026
Connect Biopharma announced new data on rademikibart, a potential best-in-class IL-4Rα antibody, highlighting its unique mechanism of action and clinical progress. Phase 1b and 2 studies are ongoing to confirm its rapid improvement in airway function for asthma and COPD, with topline results expected in 2026. The company also reported a strong financial position, with sufficient cash runway into 2027.
01-12 13:00
中概股周涨跌榜 | PomDoctor本周涨幅26.2%，叮咚买菜涨25.6%，聪链集团涨21.9%
PomDoctor涨26.2%；叮咚买菜涨25.6%；聪链集团涨21.9%
2025-12-06 09:33
美股大行评级 | 超配！BETA、BillionToOne获多家机构首予评级；摩根大通上调阿斯麦目标价升至1275美元
今日重点评级关注：RBC Capital：上调Neumora Therapeutics评级至"跑赢大市"，目标价从4美元升至7美元；HC Wainwright & Co.：维持ProMIS Neurosciences"买入"评级，目标价从4美元升至18美元
2025-12-02 09:50
Lake Street Initiates Coverage On Connect Biopharma Hldgs with Buy Rating, Announces Price Target of $9
Lake Street analyst Thomas Flaten initiates coverage on Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy rating and announces Price Target of $9.
2025-12-02 01:01
中概股周涨跌榜 | 智驾概念股爆发！禾赛、小马智行周内集体涨超20%
Amber International Holding涨84.6%；燃石医学涨51.5%；Texxon Holding涨49.6%
2025-11-29 16:15
Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference
Connect Biopharma announced that its management will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on December 2, 2025, at 10:50 a.m. ET. The live webcast will be available on the Investors section of the Connect website, with an archived replay accessible for 90 days. The company, focused on treating inflammatory diseases like asthma and COPD, is advancing rademikibart, a next-generation antibody targeting IL-4R...
2025-11-24 14:00
